How we use hepatic arterial infusion chemotherapy in the new era of systemic therapy? Comment

被引：1
作者：
Ogasawara, Sadahisa [1 ]
Kanogawa, Naoya [1 ]
Kato, Naoya [1 ]
机构：
[1] Chiba Univ, Grad Sch Med, Dept Gastroenterol, Chiba, Japan
来源：
HEPATOBILIARY SURGERY AND NUTRITION | 2022年
关键词：
HEPATOCELLULAR-CARCINOMA; CHEMOEMBOLIZATION;
D O I：
10.21037/hbsn-22-396
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：4
相关论文
共 10 条
  • [1] Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion A Randomized Clinical Trial
    He, MinKe
    Li, QiJiong
    Zou, RuHai
    Shen, JingXian
    Fang, WanQiang
    Tan, GuoSheng
    Zhou, YuanMin
    Wu, XiaoPing
    Xu, Li
    Wei, Wei
    Le, Yong
    Zhou, ZhongGuo
    Zhao, Ming
    Guo, Ying
    Guo, RongPing
    Chen, MinShan
    Shi, Ming
    [J]. JAMA ONCOLOGY, 2019, 5 (07) : 953 - 960
  • [2] Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma
    Iwamoto, Hideki
    Niizeki, Takashi
    Nagamatsu, Hiroaki
    Ueshima, Kazuomi
    Nomura, Takako
    Kuzuya, Teiji
    Kasai, Kazuhiro
    Kooka, Yohei
    Hiraoka, Atsushi
    Sugimoto, Rie
    Yonezawa, Takehiro
    Ishihara, Akio
    Deguchi, Akihiro
    Arai, Hirotaka
    Shimose, Shigeo
    Shirono, Tomotake
    Nakano, Masahito
    Okamura, Shusuke
    Noda, Yu
    Kamachi, Naoki
    Sakai, Miwa
    Suzuki, Hiroyuki
    Aino, Hajime
    Matsukuma, Norito
    Matsugaki, Satoru
    Ogata, Kei
    Yano, Yoichi
    Ueno, Takato
    Kajiwara, Masahiko
    Itano, Satoshi
    Fukuizumi, Kunitaka
    Kawano, Hiroshi
    Noguchi, Kazunori
    Tanaka, Masatoshi
    Yamaguchi, Taizo
    Kuromatsu, Ryoko
    Kawaguchi, Atsushi
    Koga, Hironori
    Torimura, Takuji
    [J]. CANCERS, 2021, 13 (04) : 1 - 14
  • [3] Analyses of Intermediate-Stage Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization prior to Designing Clinical Trials
    Koroki, Keisuke
    Ogasawara, Sadahisa
    Ooka, Yoshihiko
    Kanzaki, Hiroaki
    Kanayama, Kengo
    Maruta, Susumu
    Maeda, Takahiro
    Yokoyama, Masayuki
    Wakamatsu, Toru
    Inoue, Masanori
    Kobayashi, Kazufumi
    Kiyono, Soichiro
    Nakamura, Masato
    Kanogawa, Naoya
    Saito, Tomoko
    Kondo, Takayuki
    Suzuki, Eiichiro
    Nakamoto, Shingo
    Yasui, Shin
    Tawada, Akinobu
    Chiba, Tetsuhiro
    Arai, Makoto
    Kanda, Tatsuo
    Maruyama, Hitoshi
    Kato, Jun
    Kuboki, Satoshi
    Ohtsuka, Masayuki
    Miyazaki, Masaru
    Yokosuka, Osamu
    Kato, Naoya
    [J]. LIVER CANCER, 2020, 9 (05) : 596 - 612
  • [4] Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child-Pugh A Liver Function: A Proof-Of-Concept Study
    Kudo, Masatoshi
    Ueshima, Kazuomi
    Chan, Stephan
    Minami, Tomohiro
    Chishina, Hirokazu
    Aoki, Tomoko
    Takita, Masahiro
    Hagiwara, Satoru
    Minami, Yasunori
    Ida, Hiroshi
    Takenaka, Mamoru
    Sakurai, Toshiharu
    Watanabe, Tomohiro
    Morita, Masahiro
    Ogawa, Chikara
    Wada, Yoshiyuki
    Ikeda, Masafumi
    Ishii, Hiroshi
    Izumi, Namiki
    Nishida, Naoshi
    [J]. CANCERS, 2019, 11 (08)
  • [5] Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial
    Kudo, Masatoshi
    Ueshima, Kazuomi
    Yokosuka, Osamu
    Ogasawara, Sadahisa
    Obi, Shuntaro
    Izumi, Namiki
    Aikata, Hiroshi
    Nagano, Hiroaki
    Hatano, Etsuro
    Sasaki, Yutaka
    Hino, Keisuke
    Kumada, Takashi
    Yamamoto, Kazuhide
    Imai, Yasuharu
    Iwadou, Shouta
    Ogawa, Chikara
    Okusaka, Takuji
    Kanai, Fumihiko
    Akazawa, Kohei
    Yoshimura, Ken-ichi
    Johnson, Philip
    Arai, Yasuaki
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (06) : 424 - 432
  • [6] Hepatic Arterial Infusion of Oxaliplatin Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial
    Li, Qi-Jiong
    He, Min-Ke
    Chen, Huan-Wei
    Fang, Wan-Qiang
    Zhou, Yuan-Min
    Xu, Li
    Wei, Wei
    Zhang, Yao-Jun
    Guo, Ying
    Guo, Rong-Ping
    Chen, Min-Shan
    Shi, Ming
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (02) : 150 - +
  • [7] Transarterial infusion chemotherapy with FOLFOX for advanced hepatocellular carcinoma: a multi-center propensity score matched analysis of real-world practice
    Li, Shaohua
    Mei, Jie
    Wang, Qiaoxuan
    Shi, Feng
    Liu, Hongyan
    Zhao, Ming
    Lu, Lianghe
    Ling, Yihong
    Guo, Zhixing
    Guo, Yabing
    Chen, Xiaoming
    Shi, Ming
    Lau, Wan Yee
    Wei, Wei
    Guo, Rongping
    [J]. HEPATOBILIARY SURGERY AND NUTRITION, 2021, 10 (05) : 631 - +
  • [8] Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial
    Llovet, JM
    Real, MI
    Montaña, X
    Planas, R
    Coll, S
    Aponte, J
    Ayuso, C
    Sala, M
    Muchart, J
    Solà, R
    Rodés, J
    Bruix, J
    [J]. LANCET, 2002, 359 (9319) : 1734 - 1739
  • [9] Arterial Chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase III Trial (FOHAIC-1)
    Lyu, Ning
    Wang, Xun
    Li, Ji-Bin
    Lai, Jin-Fa
    Chen, Qi-Feng
    Li, Shao-Long
    Deng, Hai-Jing
    He, Meng
    Mu, Lu-Wen
    Zhao, Ming
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (05) : 468 - +
  • [10] Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
    Ueshima, Kazuomi
    Ogasawara, Sadahisa
    Ikeda, Masafumi
    Yasui, Yutaka
    Terashima, Takeshi
    Yamashita, Tatsuya
    Obi, Shuntaro
    Sato, Shinpei
    Aikata, Hiroshi
    Ohmura, Takumi
    Kuroda, Hidekatsu
    Ohki, Takamasa
    Nagashima, Kengo
    Ooka, Yoshihiko
    Takita, Masahiro
    Kurosaki, Masayuki
    Chayama, Kazuaki
    Kaneko, Shuichi
    Izumi, Namiki
    Kato, Naoya
    Kudo, Masatoshi
    Omata, Masao
    [J]. LIVER CANCER, 2020, 9 (05) : 583 - 595
1